Ypsomed Holding AG (XSWX:YPSN) Owner Earnings per Share (TTM): 13.76 (As of Mar. 2026) — 81% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:YPSN Ypsomed Holding AG XSWX:YPSN
91 GF Score
Price CHF390.20
GF Value CHF396.03
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Ypsomed Holding AG Owner Earnings per Share (TTM)?

Ypsomed Holding AG XSWX:YPSN -0.10% 91 Owner Earnings per Share (TTM) is 13.76 as of Mar. 2026, which is 81% below its 10-year median of 72.77. GuruFocus rates XSWX:YPSN with a GF Score™ of 91/100 and a GF Value™ of CHF396.03 (Fairly Valued). The stock has 6 warning signs investors should review. Among 309 Medical Devices & Instruments companies, Ypsomed Holding AG ranks worse than 53.72% on this metric.

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Ypsomed Holding AG's Owner Earnings per Share (TTM) ended in Mar. 2026 was CHF13.76. It's Price-to-Owner-Earnings ratio for today is 28.36.


The historical rank and industry rank for Ypsomed Holding AG's Owner Earnings per Share (TTM) or its related term are showing as below:

XSWX:YPSN' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 19.84   Med: 72.77   Max: 177.13
Current: 27.78


During the past 13 years, the highest Price-to-Owner-Earnings ratio of Ypsomed Holding AG was 177.13. The lowest was 19.84. And the median was 72.77.


XSWX:YPSN's Price-to-Owner-Earnings is ranked worse than
53.72% of 309 companies
in the Medical Devices & Instruments industry
Industry Median: 25.54 vs XSWX:YPSN: 27.78

Ypsomed Holding AG's Earnings per Share (Diluted) for the six months ended in Mar. 2026 was CHF6.11. Its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was CHF16.30. It's PE Ratio (TTM) ratio for today is 23.94.

Ypsomed Holding AG's EPS without NRI for the six months ended in Mar. 2026 was CHF6.11. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was CHF10.00. It's PE Ratio without NRI ratio for today is 39.01.


Be Aware

Assumption: Companies usually do not report maintenance capital expenditures and growth capital expenditures separately. Here we use estimated numbers and average them over 5 years. The method to estimate maintenance capital expenditures can be found in above part 4.

Note: GuruFocus' Change In Working Capital is provided by Morningstar. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement from original financial report. And it includes non-current parts of assets and liabilities.


Ypsomed Holding AG Owner Earnings per Share (TTM) Related Terms


Ypsomed Holding AG Owner Earnings per Share (TTM) Historical Data

* Premium members only.

The historical data trend for Ypsomed Holding AG's Owner Earnings per Share (TTM) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ypsomed Holding AG Owner Earnings per Share (TTM) Chart

Ypsomed Holding AG Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Owner Earnings per Share (TTM)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.95 2.10 2.91 -1.87 13.76

Ypsomed Holding AG Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Owner Earnings per Share (TTM) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.91 0.00 -1.87 0.00 13.76

XSWX:YPSN vs ISRG, BDX, MDLN: Owner Earnings per Share (TTM) Comparison

For the Medical Instruments & Supplies subindustry, Ypsomed Holding AG's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ypsomed Holding AG Price-to-Owner-Earnings vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ypsomed Holding AG's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Ypsomed Holding AG's Price-to-Owner-Earnings falls into.


XSWX:YPSN
91GF Score
Ypsomed Holding AG XSWX:YPSN
Owner Earnings per Share (TTM) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ypsomed Holding AG Owner Earnings per Share (TTM) Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

To make it simple, then you will have:

Owner Earnings per Share (TTM) = (Net Income + Depreciation, Depletion and Amortization + Change In Deferred Tax - 5Y Average of Maintenance Capital Expenditure + Change In Working Capital) / Shares Outstanding (Diluted Average)

Ypsomed Holding AG's Owner Earnings per Share (TTM) Calculation:

Last Year Average of Last 5 Years
Net Income 221.9
Depreciation, Depletion and Amortization 82.2
Change In Deferred Tax 0.0
5Y Average of Maintenance Capital Expenditure 167.6
Change In Working Capital 50.8
Shares Outstanding (Diluted Average) 13.6

1. Start with "Net Income" from income statement. Ypsomed Holding AG's Net Income for the trailing twelve months (TTM) ended in Mar. 2026 was CHF221.9 Mil.

2. "Depreciation, Depletion and Amortization" is from cashflow statement. Ypsomed Holding AG's Depreciation, Depletion and Amortization for the trailing twelve months (TTM) ended in Mar. 2026 was CHF82.2 Mil. This needs to be added back because company does not actually need to pay cash for it. It is a non-cash item.

3. Other non-cash charges usually include "Stock Based Compensation" and "Change In Deferred Tax":
However, to be conservative, GuruFocus will not add Stock Based Compensation back to net income. Ypsomed Holding AG's Change In Deferred Tax for the trailing twelve months (TTM) ended in Mar. 2026 was CHF0.0 Mil.

4. Average maintenance capital expenditure over a business/industry cycle: 5-Year Average Maintenance Capital Expenditure = CHF167.6 Mil

It is usually best to take a long-term average of maintenance capital expenditure. Ideally this would be as long as 10 years and include at least one economic downturn. However, since many companies do not have as long as 10-year history, here GuruFocus uses the latest 5 years data to do the calculation. To smooth out unusual years but reflect recent developments, we take an average of the 5 year maintenance capital expenditure.

The following shows how to get maintenance capital expenditure.

First, calculate the revenue change regarding to the previous year. If the revenue decreased from the previous year, then the Maintenance Capital Expenditure = Capital Expenditure (positive).
Second, if the revenue increased from the previous year, then calculate the percentage of Net PPE as of corresponding Revenue.
Growth Capital Expenditure = Percentage of Property, Plant and Equipment as of corresponding Revenue * Revenue Increase
Third, calculate Capital Expenditure (positive) - Growth Capital Expenditure.
If [Capital Expenditure (positive) - Growth Capital Expenditure] was negative, then the Maintenance Capital Expenditure = Capital Expenditure (positive).
If [Capital Expenditure (positive) - Growth Capital Expenditure] was positive, then the Maintenance Capital Expenditure = Capital Expenditure (positive) - Growth Capital Expenditure.
Fourth, get the average of the 5 years maintenance capital expenditure.

Ypsomed Holding AG's 5-Year Average Maintenance Capital Expenditure = CHF167.6 Mil

5. "Change In Working Capital" is from cashflow statement. Ypsomed Holding AG's Change In Working Capital for the trailing twelve months (TTM) ended in Mar. 2026 was CHF50.8 Mil.
Note: GuruFocus' Change in Working Capital is provided by Morningstar. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement from original financial report. And sometimes it includes non-current parts of assets and liabilities.

6. Ypsomed Holding AG's Shares Outstanding (Diluted Average) for the months ended in Mar. 2026 was 13.608 Mil.

Ypsomed Holding AG's Onwer Earnings Per Share for Mar. 2026 is calculated as:

Owner Earnings per Share (TTM)
=( Net Income+Depreciation, Depletion and Amortization+Change In Deferred Tax
=( 221.927 +82.211+0
-5Y Avg of Maintenance CAPEX+Change In Working Capital )/Shares Outstanding (Diluted Average)
-167.6194+50.774)/13.608
=13.76

Price-to-Owner-Earnings=Current Price/Owner Earnings per Share (TTM)
=390.20/13.76
=28.36

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Owner Earnings per Share (TTM) of 13.76 mean?
Ypsomed Holding AG (XSWX:YPSN) has a Owner Earnings per Share (TTM) of 13.76 as of Mar. 2026. Warren Buffett defined owner earnings as reported earnings plus depreciation less average maintenance capital expenditure. View historical data on Ypsomed Holding AG. This is 81% below median its historical median of 72.77. Over the past decade, Ypsomed Holding AG's Owner Earnings per Share (TTM) has ranged from 19.84 to 177.13. According to the industry distribution chart, Ypsomed Holding AG ranks #166 out of 309 companies in the Medical Devices & Instruments industry, placing it in the top 53.7%.
Is Ypsomed Holding AG's Owner Earnings per Share (TTM) too high?
Ypsomed Holding AG's current Owner Earnings per Share (TTM) of 13.76 is 81% below median its 10-year median of 72.77. Over the past 10 years, this metric has ranged from a low of 19.84 to a high of 177.13. The Medical Devices & Instruments industry median Owner Earnings per Share (TTM) is 25.54. Ypsomed Holding AG's value of 13.76 is 46.1% below this industry median. Based on the distribution chart, Ypsomed Holding AG ranks #166 out of 309 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Ypsomed Holding AG has a GF Score™ of 91/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ypsomed Holding AG's Owner Earnings per Share (TTM) compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Ypsomed Holding AG ranks #166 out of 309 companies for Owner Earnings per Share (TTM). This places Ypsomed Holding AG in the lower half of its industry. The industry median Owner Earnings per Share (TTM) is 25.54. Ypsomed Holding AG's value of 13.76 is 46.1% below this benchmark. Historically, Ypsomed Holding AG's own Owner Earnings per Share (TTM) has ranged from 19.84 to 177.13 over the past decade. While the company's 10-year median is 72.77 vs. the industry median of 25.54, Ypsomed Holding AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Owner Earnings per Share (TTM) for a Medical Devices & Instruments company?
The median Owner Earnings per Share (TTM) among Medical Devices & Instruments companies is 25.54, based on 309 companies in the industry. Companies in the top quartile (top 25%) have a Owner Earnings per Share (TTM) significantly above this median, while those in the bottom quartile fall well below. However, Owner Earnings per Share (TTM) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ypsomed Holding AG's current Owner Earnings per Share (TTM) of 13.76 is 46.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Owner Earnings per Share (TTM) mean?
A high Owner Earnings per Share (TTM) can signal that a stock is expensive relative to its fundamentals. Warren Buffett defined owner earnings as reported earnings plus depreciation less average maintenance capital expenditure. View historical data on Ypsomed Holding AG. For the Medical Devices & Instruments industry, the median Owner Earnings per Share (TTM) is 25.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ypsomed Holding AG's current Owner Earnings per Share (TTM) is 13.76, which is 81% below median its own 10-year median of 72.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ypsomed Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Ypsomed Holding AG (XSWX:YPSN) is currently considered Fairly Valued. The stock's GF Value™ is CHF396.03, compared to a current price of CHF390.20 — trading 1.5% below its estimated fair value. The current Owner Earnings per Share (TTM) is 13.76, which is 81% below median its 10-year median of 72.77 and 46.1% below the Medical Devices & Instruments industry median of 25.54. Ypsomed Holding AG's overall GF Score™ is 91/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Owner Earnings per Share (TTM) calculated?
Owner Earnings per Share (TTM) is calculated from a company's financial statements. For Ypsomed Holding AG (XSWX:YPSN), the current Owner Earnings per Share (TTM) is 13.76 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ypsomed Holding AG (XSWX:YPSN) Overvalued in 2026?

Based on GuruFocus' analysis, Ypsomed Holding AG stock appears to be undervalued. The current stock price of CHF390.20 is trading 1.5% below its estimated GF Value™ of CHF396.03. GuruFocus considers Ypsomed Holding AG to be Fairly Valued.

Key valuation signals for XSWX:YPSN:

  • Owner Earnings per Share (TTM): 13.76 (81% below median its 10-year median of 72.77)
  • GF Value™: CHF396.03 vs. price of CHF390.20 (1.5% below fair value)
  • GF Score™: 91/100 with 6 warning signs
  • Industry Position: 46.1% below the Medical Devices & Instruments median (#166 of 309)

No single metric tells the full story. See the XSWX:YPSN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ypsomed Holding AG Business Description

Other Exchanges YPSNz:UK0QLQ:UKOWX:Germany
Address Brunnmattstrasse 6, Burgdorf, CHE, 3401
Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a click-on function. The company operates under two reportable segments: Ypsomed Delivery Systems and Ypsomed Diabetes Care.
91GF Score

Get the complete analysis for XSWX:YPSN

Owner Earnings per Share (TTM) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF390.20
Price
CHF396.03
GF Value